Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

3.6K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.6K
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

4.9K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.9K
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

4.6K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
4.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Computational Identification of Active Drug Metabolites for Human Protein Targets.

Molecular pharmaceutics·2026
Same author

CRUSH-Cleavage Rules Using SMIRKS Heuristics: an enhanced molecular fragmentation algorithm.

Journal of cheminformatics·2026
Same author

Developing Predictive Models by Sharing Predictions - An Investigation of a Federated Learning Approach for ADMET Predictions.

Journal of medicinal chemistry·2026
Same author

Assays for Measuring the Cell Permeability of Proteolysis-Targeting Chimeras (PROTACs): Performance, Correlations, Applicability and Recommendations.

Molecular pharmaceutics·2026
Same author

Meeting report of the 6th European Biotransformation Workshop.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same author

Advancing Reproducibility and Open Data in Theoretical and Computational Chemistry.

Journal of chemical theory and computation·2026

Related Experiment Video

Updated: Jan 14, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.2K

Metabolite Identification Data in Drug Discovery, Part 2: Site-of-Metabolism Annotation, Analysis, and Exploration

Ya Chen1,2, Susanne Winiwarter3, Roxane Axel Jacob1,4

  • 1Department of Pharmaceutical Sciences, Division of Pharmaceutical Chemistry, Faculty of Life Sciences, University of Vienna, Josef-Holaubek-Platz 2, 1090 Vienna, Austria.

Molecular Pharmaceutics
|October 21, 2025
PubMed
Summary
This summary is machine-generated.

Predicting sites of metabolism (SoMs) is crucial for drug design. This study introduces a new method for annotating SoM data, improving machine learning predictions and releasing valuable public data.

Keywords:
data analysisdata annotationdata setsdrug metabolismsites of metabolism (SoMs)xenobiotic metabolism

More Related Videos

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

4.2K
Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
07:34

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

13.3K

Related Experiment Videos

Last Updated: Jan 14, 2026

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis
07:11

Author Spotlight: Emerging Technologies and Advanced Tools for Decoding Metabolomics Data Analysis

Published on: November 10, 2023

3.2K
An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome
05:35

An Integrated Workflow of Identification and Quantification on FDR Control-Based Untargeted Metabolome

Published on: September 20, 2022

4.2K
Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS
07:34

Large Scale Non-targeted Metabolomic Profiling of Serum by Ultra Performance Liquid Chromatography-Mass Spectrometry UPLC-MS

Published on: March 14, 2013

13.3K

Area of Science:

  • Drug discovery and development
  • Medicinal chemistry
  • Pharmacokinetics

Background:

  • Accurate prediction of sites of metabolism (SoMs) is vital for designing safe and effective small molecules.
  • Limited availability of annotated SoM data impedes the progress of data-driven prediction methods, including machine learning.
  • Existing SoM datasets often lack comprehensive characterization and do not fully account for experimental data uncertainty.

Purpose of the Study:

  • To comprehensively characterize SoM data from human hepatocyte assays.
  • To develop and validate a novel strategy for SoM annotation that incorporates experimental uncertainty.
  • To enhance the accuracy of SoM prediction models using newly generated and analyzed metabolism data.

Main Methods:

  • Acquisition and characterization of SoM data from human hepatocyte assays.
  • Development of a new SoM annotation strategy addressing data uncertainty.
  • Entropy analysis of SoM annotations to understand data complexity.
  • Evaluation of the impact of new data on SoM prediction model performance.

Main Results:

  • A substantial dataset of SoM annotations was generated and characterized.
  • The novel annotation strategy effectively handles uncertainty in experimental metabolism data.
  • Entropy analysis revealed complexities in interpreting metabolism data.
  • The newly available data significantly improved the performance of SoM prediction models.

Conclusions:

  • The developed SoM annotation strategy enhances the reliability of metabolism data for computational modeling.
  • The public release of this comprehensive SoM dataset will accelerate the advancement of machine learning-based metabolism prediction.
  • This work provides a valuable resource for researchers in drug discovery aiming to optimize small molecule properties.